In fact, only the simultaneous ablation of CP and hephaestin (HEPH) genes in mice is able to recapitulate symptoms consistent with those shown by aceruloplasminemia patients, suggesting that hephaestin can compensate the lack of CP in mice, but not in humans [21,22]. The gene discussed is HEPH; the disease is aceruloplasminemia.